Efficacy and safety of intravenous thrombolytic therapy using Reteplase and Urokinase for the treatment of acute myocardial infarction: A Meta-analysis

doi:10.3969/j.issn.1672-5301.2014.12.001

Home>Articles>Efficacy and safety of intravenous thrombolytic therapy using Reteplase and Urokinase for the treatment of acute myocardial infarction: A Meta-analysis

DOI: 10.3969/j.issn.1672-5301.2014.12.001

Efficacy and safety of intravenous thrombolytic therapy using Reteplase and Urokinase for the treatment of acute myocardial infarction: A Meta-analysis

Keywords：ReteplaseUrokinaseThrombolysisAcute myocardial infarctionEfficacySafety

Publication Date：2014-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：7( 1057-1063 )

Chinese Journal of Cardiovascular Research

ISTIC

ISSN：1672-5301

Year, Vol.(Issue)：2014,12(12)